Orthostatic Hypotension

Key Facts

  • Orthostatic hypotension is most bothersome in moderate to advanced patients.
  • Dopaminergic medication may be the cause.
  • Patients may not associate orthostatic hypotension with PD.

Clinical Best Practices

  • Evaluate factors that could contribute to orthostatic hypotension and instruct the patient in safety measures.
  • Consider options before initiating pharmacological treatment<.

Orthostatic hypotension can affect 20% to 50% of PD patients. It can occur at any stage, but usually is most bothersome in moderate to advanced patients. If occurring early, consider alternative diagnoses such as multiple system atrophy.


  • Dizziness or lightheadedness
  • Generalized weakness
  • Clouded mentation
  • Syncope

Common Causes


  • Clinical history and physical examination—24-hour blood pressure (BP) monitor, measurement of orthostatic BP after standing for 3 minutes or home monitoring of orthostatic BP will help in making the diagnosis

Barriers to Diagnosis 

  • Lack of patient insight–you must have an informed other (spouse or family member)
  • Lack of disclosure

Treatment Options

  • First, consider reducing or stopping antihypertensive agents.
  • Encourage hydration and compression stockings.
  • Consider droxydopa<. Previously, fludrocortisone (monitor potassium), midodrine or indomethacin have been used.
  • Patient education is important.

Important Caveats to Therapy 


Wood LD, Neumiller JL, Setter SM, Dobbins EK. Clinical review of treatment options for select nonmotor symptoms of Parkinson’s disease. Am J Geriatr Pharmacother. 2010;8(4):294-315.

Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL. Orthostatic hypotension in patients with Parkinson’s disease: pathophysiology and management. Drugs Aging. 2001;18(7):495-505.